Part III: China’s Future in Global Clinical Research

Part III: China’s Future in Global Clinical Research

Active international collaboration has facilitated the rise of the Asia-Pacific region in global clinical research. In the first two parts of this blog series, we’ve discussed how Japan and So […]

了解更多

2016年12月7日

Part II: Insights on the Clinical Trial Landscape of South Korea

Japan has taken significant steps in establishing itself as a major player in the global clinical research community, driving the demand for more clinical trials across East Asia as a result.  […]

了解更多

2016年12月5日

Part I – The clinical trial landscape of the Asia-Pacific, Japan

On the heels of our recent post on our presence at this week’s DIA Japan 2015, BBK welcomes Philip Gregory, the General Manager of 乔治临床( George Clinical ) – CRO China as our guest contri […]

了解更多

2016年12月3日

Excellent infrastructure and site quality that attracts global clinical trials to Korea

The rising presence of clinical trials (CT) in the Asia-Pacific region is predominantly driven by the East Asian region which includes China, Japan, Korea, Taiwan and Hong Kong. Over the past decade, Korea has become a global clinical trial hub and is one of the leading clinical trial destinations in the Asian region; with approximately […]

了解更多

2016年11月5日

乔治临床( George Clinical ) achieves Medidata Rave accreditation

乔治临床( George Clinical ), a leading Asia-Pacific CRO, have now achieved Medidata Rave® accreditation. Adding this platform to 乔治临床( George Clinical )’s robust stable of electronic data co […]

了解更多

2016年10月13日

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )